ITPD920145A1 - Uso terapeutico della fosforil-l-serina-n-acil-sfingosina - Google Patents
Uso terapeutico della fosforil-l-serina-n-acil-sfingosinaInfo
- Publication number
- ITPD920145A1 ITPD920145A1 IT000145A ITPD920145A ITPD920145A1 IT PD920145 A1 ITPD920145 A1 IT PD920145A1 IT 000145 A IT000145 A IT 000145A IT PD920145 A ITPD920145 A IT PD920145A IT PD920145 A1 ITPD920145 A1 IT PD920145A1
- Authority
- IT
- Italy
- Prior art keywords
- sphingosine
- phosphoryl
- serine
- acyl
- pct
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITPD920145A IT1260155B (it) | 1992-08-03 | 1992-08-03 | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina |
CA002141557A CA2141557A1 (en) | 1992-08-03 | 1993-08-02 | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
EP93917729A EP0652755B1 (en) | 1992-08-03 | 1993-08-02 | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
AU47062/93A AU4706293A (en) | 1992-08-03 | 1993-08-02 | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
DE69307895T DE69307895T2 (de) | 1992-08-03 | 1993-08-02 | Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin |
JP6505008A JPH07509478A (ja) | 1992-08-03 | 1993-08-02 | ホスホリル−l−セリン−n−アシル−スフィンゴシンの治療用使用 |
AT93917729T ATE148345T1 (de) | 1992-08-03 | 1993-08-02 | Therapeutische verwendung von phosphoryl-l-serin- n-acyl-sphingosin |
US08/374,624 US5556843A (en) | 1992-08-03 | 1993-08-02 | Therapeutic use of phosphoryl-L-serine-N-acyl-sphingosine |
ES93917729T ES2101334T3 (es) | 1992-08-03 | 1993-08-02 | Utilizacion terapeutica de la fosforil-l-serina-n-acil-esfingosina. |
PCT/EP1993/002061 WO1994003178A1 (en) | 1992-08-03 | 1993-08-02 | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITPD920145A IT1260155B (it) | 1992-08-03 | 1992-08-03 | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina |
Publications (3)
Publication Number | Publication Date |
---|---|
ITPD920145A0 ITPD920145A0 (it) | 1992-08-03 |
ITPD920145A1 true ITPD920145A1 (it) | 1994-02-03 |
IT1260155B IT1260155B (it) | 1996-03-28 |
Family
ID=11390037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITPD920145A IT1260155B (it) | 1992-08-03 | 1992-08-03 | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina |
Country Status (10)
Country | Link |
---|---|
US (1) | US5556843A (it) |
EP (1) | EP0652755B1 (it) |
JP (1) | JPH07509478A (it) |
AT (1) | ATE148345T1 (it) |
AU (1) | AU4706293A (it) |
CA (1) | CA2141557A1 (it) |
DE (1) | DE69307895T2 (it) |
ES (1) | ES2101334T3 (it) |
IT (1) | IT1260155B (it) |
WO (1) | WO1994003178A1 (it) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
EP0821068A3 (en) * | 1996-03-29 | 1999-06-02 | Rohm And Haas Company | Novel sphingolipids and a process thereto |
EP1293124A3 (en) * | 1996-03-29 | 2003-04-09 | Dow AgroSciences LLC | Method of treatment of plants with sphingolipids |
DE69838789T2 (de) * | 1997-03-12 | 2008-10-30 | Suzanne Cambridge de la Monte | Verfahren zur behandlung oder prävention der alzheimerischen krankheit |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
JP2002532416A (ja) * | 1998-12-17 | 2002-10-02 | マインドセット・バイオファーマシューティカルズ・(ユーエスエイ)・インコーポレイテッド | 脳のグルコース利用の増進 |
US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
KR20020027463A (ko) * | 1999-07-12 | 2002-04-13 | 우에노 도시오 | 스핀고신-1-인산 수용체 아고니스트 또는스핀고신-1-인산을 유효 성분으로서 함유하는 선유화 억제제 |
AR074061A1 (es) * | 2008-10-31 | 2010-12-22 | Lexicon Pharmaceuticals Inc | Inhibidores de s1p liasa para el tratamiento de la malaria cerebral y formulacion farmaceutica |
KR20170025909A (ko) | 2015-08-31 | 2017-03-08 | 가천대학교 산학협력단 | 스핑고신 1-인산 또는 Sphk2의 발현을 상승시키는 물질을 포함하는 대사 기능 장애의 예방 또는 치료용 약학 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01135720A (ja) * | 1987-11-20 | 1989-05-29 | Eisai Co Ltd | 神経線維再生剤 |
-
1992
- 1992-08-03 IT ITPD920145A patent/IT1260155B/it active IP Right Grant
-
1993
- 1993-08-02 ES ES93917729T patent/ES2101334T3/es not_active Expired - Lifetime
- 1993-08-02 JP JP6505008A patent/JPH07509478A/ja active Pending
- 1993-08-02 DE DE69307895T patent/DE69307895T2/de not_active Expired - Fee Related
- 1993-08-02 WO PCT/EP1993/002061 patent/WO1994003178A1/en active IP Right Grant
- 1993-08-02 US US08/374,624 patent/US5556843A/en not_active Expired - Fee Related
- 1993-08-02 EP EP93917729A patent/EP0652755B1/en not_active Expired - Lifetime
- 1993-08-02 AU AU47062/93A patent/AU4706293A/en not_active Abandoned
- 1993-08-02 CA CA002141557A patent/CA2141557A1/en not_active Abandoned
- 1993-08-02 AT AT93917729T patent/ATE148345T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE148345T1 (de) | 1997-02-15 |
CA2141557A1 (en) | 1994-02-17 |
EP0652755B1 (en) | 1997-01-29 |
WO1994003178A1 (en) | 1994-02-17 |
ES2101334T3 (es) | 1997-07-01 |
IT1260155B (it) | 1996-03-28 |
DE69307895T2 (de) | 1997-08-14 |
JPH07509478A (ja) | 1995-10-19 |
AU4706293A (en) | 1994-03-03 |
US5556843A (en) | 1996-09-17 |
DE69307895D1 (de) | 1997-03-13 |
ITPD920145A0 (it) | 1992-08-03 |
EP0652755A1 (en) | 1995-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG55184A1 (en) | New imidazopyridines | |
MX9601360A (es) | Mezcla estabilizante sinergistica. | |
FI961506A (fi) | Distamysiini A -analogit antituumorisina ja antiviraalisina aineina | |
DK0736039T3 (da) | Forbindelser med væksthormon-frigivende egenskaber | |
DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
ES2111925T3 (es) | Piridinas herbicidas sustituidas con heterociclos. | |
DE69326250D1 (de) | Neuropeptide y antagoniste | |
AP9200410A0 (en) | Retroviral protease inhibitors. | |
ITPD920145A1 (it) | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina | |
MX9801190A (es) | Inhibidores de prolil endopeptidasa. | |
NO985187L (no) | Taxanderivater, deres fremstilling og formuleringer som inneholder dem | |
HUT73231A (en) | Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis | |
FI952855A0 (fi) | Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö | |
ES2140683T3 (es) | Procedimiento para preparar compuestos de benzopirano. | |
ATE206127T1 (de) | Inhibitoren retroviraler proteasen | |
DK0850225T3 (da) | Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960701 |